Latest News
-

2025: Year in Review
⏱️34 min read | As we usher in 2026, we look back on the landmark clinical trial findings, advancements in research, regulatory disappointments, and thunderous community unity that will define 2025 for the Huntington’s disease community.
-

Mutant yeast highlights crucial CAG-reading protein
A new job for a DNA-reading protein called SPT4 – controlling the balance of mutant and healthy huntingtin protein
-

HD Therapeutics Conference 2012 Updates: Day 3
Day 3 of our coverage of the Huntington's Disease Therapeutics Conference
-

HD Therapeutics Conference 2012 Updates: Day 2
Day 2 of our coverage of the Huntington's Disease Therapeutics Conference
-

HD Therapeutics Conference 2012 Updates: Day 1
Day 1 of our coverage of the Huntington's Disease Therapeutics Conference
-

Coming soon: HD Therapeutics Conference 2012
Huntington's Disease Therapeutics Conference starts next week. Twitter follow @HDBuzzfeed for live updates!
-

New analysis suggests 'small' CAG length doesn't matter after all
Size isn't everything: new research suggests that only a person's big CAG count, not the small one, affects HD onset
-

Special 'brain fat' injection helps HD mice
Directly injecting the brains of HD mice with a good type of fat called ganglioside GM1 provides dramatic benefit
-

HDYO! Huntington's Disease Youth Organization goes live
The Huntington's Disease Youth Organization website has just launched and its website is now active at www.hdyo.org
-

Could mesenchymal stem cells deliver gene silencing drugs?
Stem cells can deliver HD gene silencing drugs into cells in a dish. Do we need another delivery technology?

